Increased fibrinogen, D-dimer and galectin-3 levels in patients with migraine
dc.contributor.author | Yucel, Yavuz | |
dc.contributor.author | Tanriverdi, Halis | |
dc.contributor.author | Arikanoglu, Adalet | |
dc.contributor.author | Varol, Sefer | |
dc.contributor.author | Kaplan, Ibrahim | |
dc.contributor.author | Akil, Esref | |
dc.contributor.author | Celepkolu, Tahsin | |
dc.date.accessioned | 2024-04-24T16:02:01Z | |
dc.date.available | 2024-04-24T16:02:01Z | |
dc.date.issued | 2014 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | There are limited studies evaluating the fibrinogen levels in patients with migraine. It remains unknown whether the levels of the haematological marker of thromboembolism, d-dimer, and the levels of galectin-3, which plays an important role in inflammation as a proinflammatory mediator, change during the attacks in patients with migraine. The present study aims to compare galectin-3, fibrinogen and d-dimer levels in patients with migraine during the attacks and interictal periods, and to compare galectin-3, fibrinogen and d-dimer levels between patients with migraine and healthy controls to investigate the role of these parameters in the pathogenesis of migraine. Fifty-nine patients with migraine and 30 age-gender matched healthy control subjects were enrolled in the study. Blood galectin-3, fibrinogen and d-dimer levels were measured in patients with migraine. Patients with migraine had higher levels of galectin-3, fibrinogen and d-dimer compared to the healthy controls (p < 0.05). No statistically significant difference was found between galectin-3 and fibrinogen levels during the attacks and interictal period in the migraine group (p > 0.05). Migraine patients had higher d-dimer levels during the attacks compared to the patients in the interictal period in the migraine group (p = 0.05). In conclusion, we found increased levels of fibrinogen, d-dimer and galectin-3 in patients with migraine compared to the healthy control group. Furthermore, we showed increased galectin-3 levels in patients with migraine, and higher d-dimer levels during migraine attacks compared to the interictal periods for the first time. These findings may be associated with the hypercoagulability and neurogenic inflammation during migraine headaches. | en_US |
dc.identifier.doi | 10.1007/s10072-013-1542-2 | |
dc.identifier.endpage | 549 | en_US |
dc.identifier.issn | 1590-1874 | |
dc.identifier.issn | 1590-3478 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 24057117 | |
dc.identifier.scopus | 2-s2.0-84897062195 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 545 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s10072-013-1542-2 | |
dc.identifier.uri | https://hdl.handle.net/11468/14570 | |
dc.identifier.volume | 35 | en_US |
dc.identifier.wos | WOS:000333123500007 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Springer-Verlag Italia Srl | en_US |
dc.relation.ispartof | Neurological Sciences | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Migraine | en_US |
dc.subject | Pathogenesis | en_US |
dc.subject | Fibrinogen | en_US |
dc.subject | Galectin-3 | en_US |
dc.subject | D-Dimer | en_US |
dc.title | Increased fibrinogen, D-dimer and galectin-3 levels in patients with migraine | en_US |
dc.title | Increased fibrinogen, D-dimer and galectin-3 levels in patients with migraine | |
dc.type | Article | en_US |